Gynecology Book

http://www.fpnotebook.com/

Loestrin 1/20

Advertisement

  1. See Also
    1. Oral Contraceptive
    2. Oral Contraceptive Drug Interaction
    3. Oral Contraceptive Selection
    4. Oral Contraceptive Side Effect Management
    5. Oral Contraceptive-Related Uterine Bleeding Management
  2. Preparations (Norethindrone Acetate / Ethinyl Estradiol)
    1. Loestrin (1.0 / 20)
  3. Components
    1. Norethindrone Acetate 1.0 mg (see preparation above)
    2. Ethinyl Estradiol 20 ug
  4. Effects
    1. Relative Progestational Activity: 1.2 (high)
    2. Estrogenic Activity: 13 (low)
    3. Androgenic Activity: 0.53 (high)
  5. Pill associated problems
    1. Indications to switch to Alesse
      1. Acne Vulgaris (lower androgen)
      2. Increased Appetite (lower Progestin)
      3. Headaches (lower Estrogen)
      4. Moodiness (less Estrogen or more Progestin)
      5. Weight gain (less Estrogen or more Progestin)
    2. Indications to switch to Loestrin 1.5/30
      1. Libido decreased (more androgen)
      2. Break-through bleed days 10-21 (more Progestin)
      3. Heavy Menses (more Progestin or less Estrogen)
      4. Dysmenorrhea or Menstrual Cramps (more Progestin)
    3. Indications to switch to Estrostep
      1. Breast Tenderness or engorgement (lower Estrogen)
    4. Indications to switch to Ortho Novum 1/35
      1. Break-through bleed days 1-9 (more Estrogen)
      2. Break-through bleed all of month (more Estrogen)
      3. Menses too light (more Estrogen, less Progestin)
    5. Indications to switch to Ortho Cyclen
      1. Major Depression provoked (lower Progestin)
  6. References
    1. Cerel-Suhl (1999) Am Fam Physician 60(7):2073
    2. Speroff (1993) Obstet Gynecol 81:1034
    3. Dickey (1998) Managing Contraceptive Pill Patients

Navigation Tree